Scientifically validated


Scientifically proven to kill pathogens and lower HCAI’s

Scientifically validated

Proven and tested

Independent labs have validated and certified the effectiveness of the T-1000 against a host of pathogens. All clinical studies showed positive results and confirmed the T-1000’s ability to inactivated pathogens. Peer-reviewed studies have also been conducted showcasing UV-C disinfections effect on lowering   healthcare-associated-infections (HCAI’s) within health care facilities.

Copy of Copy of Copy of Untitled-21
Copy of Untitled-78
Copy of Untitled-79
Copy of Untitled-80

Scientific research and evidence papers

Enhanced disinfection leads to reduction of microbial contamination and a decrease in patient colonization and infection

William A. Rutala PhD, MPH, Hajime Kanamori MD, PhD, MPH, Maria F. Gergen MT (ASCP), Lauren P. Knelson MSPH, Emily E. Sickbert-Bennett PhD, MS, Luke F. Chen MBBS, MPH, MBA, Deverick J. Anderson MD, MPH, Daniel J. Sexton MD, David J. Weber MD, MPH and the CDC Prevention Epicenters Program



Rapid and complete inactivation of SARS-CoV-2 by ultraviolet-C irradiation

Nadia Storm, Lindsay McKay, Sierra Downs, Rebecca Johnson, Dagnachew Birru, Marc de Samber, Walter Willaert, Giovanni Cennini, Anthony Griffiths


Effectiveness of targeted enhanced terminal room disinfection on hospital-wide acquisition and infection with multidrug-resistant organisms and Clostridium difficile: a secondary analysis of a multicentre cluster randomised controlled trial with crossover design

Deverick J Anderson, MD, Rebekah W Moehring, MD, Prof David J Weber, MD, Sarah S Lewis, MD, Luke F Chen, MBBS, J Conrad Schwab, MD, Paul Becherer, MD, Michael Blocker, MD, Patricia F Triplett, MD, Lauren P Knelson, MSPH, Yuliya Lokhnygina, PhD, Prof William A Rutala, PhD, Prof Daniel J Sexton, MD


Enhanced terminal room disinfection and acquisition and infection caused by multidrug-resistant organisms and Clostridium difficile (the Benefits of Enhanced Terminal Room Disinfection study): a cluster-randomised, multicentre, crossover study

Dr Deverick J Anderson, MD, Dr Deverick J Anderson, Dr Deverick J Anderson, Luke F Chen, MBBS, Prof David J Weber, MD, Rebekah W Moehring, MD, Sarah S Lewis, MD, Patricia F Triplett, MD, Michael Blocker, MD, Paul Becherer, MD, J Conrad Schwab, MD, Lauren P Knelson, MSPH, Yuliya Lokhnygina, PhD, William A Rutala, PhD, Hajime Kanamori, MD, Maria F Gergen, MT ASCP, Prof Daniel J Sexton, MD for the CDC Prevention Epicenters Program


Implementation and impact of ultraviolet environmental disinfection in an acute care setting


Janet P. Haas, PhD, RN, Jonathan Menz, MBA, Stephen Dusza, DrPH, Marisa A. Montecalvo, MD



Clostridium difficile infections before and during use of ultraviolet disinfection

Aarathi Nagaraja, MD, Paul Visintainer, PhD, Janet P. Haas, PhD, Jonathan Menz, MBA, Gary P. Wormser, MD, Marisa A. Montecalvo, MD 


Deployment of a touchless ultraviolet light robot for terminal room disinfection: The importance of audit and feedback

Michele Fleming MSN, RN, CIC *, Amie Patrick BSN, RN, Mark Gryskevicz, Nadia Masroor MPH, BS, Lisa Hassmer MBA, Kevin Shimp MSN, RN, Kaila Cooper MSN, RN, CIC, Michelle Doll MD, MPH, Michael Stevens MD, MPH, Gonzalo Bearman MD, MPH


Implementation Lessons Learned From the Benefits of Enhanced Terminal Room (BETR) Disinfection Study: Process and Perceptions of Enhanced Disinfection with Ultraviolet Disinfection Devices

Deverick J. Anderson, MD;1 Lauren P. Knelson, MSPH;1 Rebekah W. Moehring, MD, MPH;1,3 Sarah S. Lewis, MD, MPH;1 David J. Weber, MD, MPH;2 Luke F. Chen, MBBS, MPH;1 Patricia F. Triplett, MD;2,4 Michael Blocker, MD;5,6 R. Marty Cooney, MPH, MSE, BSN;7 J. Conrad Schwab, MD;8 Yuliya Lokhnygina, PhD;9 William A. Rutala, PhD;2 Daniel J. Sexton, MD1 for the CDC Prevention Epicenters Program


science of UV-C Light 

shorter the wavelength the better

UV-C light is a subsection of the electromagnetic spectrum. It has the ability to destroy pathogens genetic make up by creating chemical reactions in their nucleic acids. This damages their RNA or DNA beyond repair making them longer infectious.